Please login to the form below

Not currently logged in
Email:
Password:

palbociclib

This page shows the latest palbociclib news and features for those working in and with pharma, biotech and healthcare.

NICE gives Lilly’s Verzenios chance to compete with rivals

NICE gives Lilly’s Verzenios chance to compete with rivals

Ibrance (palbociclib) was the first of these drugs to reach the market and has already achieved blockbuster status worldwide, earning around $4bn in 2018, and forecast to hit $6bn by 2022. ... Abemaciclib has been shown to be just as effective as

Latest news

More from news
Approximately 7 fully matching, plus 46 partially matching documents found.

Latest Intelligence

  • Engaging the digital healthcare professional Engaging the digital healthcare professional

    When NICE, the UK policymaker for health spending, rejected Pfizer’s breast cancer drug palbociclib for routine funding on the NHS in February, it tweeted the news and invited comments on ... Weeks later, following the NICE consultation period, the

  • Pharma deals during August 2013 Pharma deals during August 2013

    Palbociclib, which is the result of an early partnership with Pfizer and now being developed by Pfizer, is in phase III trials for advanced breast cancer and certain haematologic malignancies. ... If approved, Onyx will receive an 8 per cent royalty on

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Synergy Vision

    Pfizer have recently announced that they will provide the breast cancer drug, palbociclib, free of charge to patients.

  • Pharma and free medicines: a different perspective

    The cost of a full course of treatment with palbociclib is approximately £80, 000. ... Therefore, it will be interesting to see the final ruling of NICE on palbociclib. .

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics